Unibest

Pharmaceutical intermediates

Eluxadoline Intermediates

10 pharmaceutical intermediates for Eluxadoline. Indication: Constipation.

提交项目All intermediates

About Eluxadoline

Originator
Actavis; Janssen Pharmaceuticals
Indication
Constipation
Approved Date
05/27/2015
DS/DP
07/07/2028

Available intermediates

10 intermediates currently listed for Eluxadoline. Request specifications, documentation or a quotation for any item below.

Eluxadoline intermediates
Product NameCAS No.Molecular FormulaPhysical Properties
L-Serine56-45-1//
L-Serine methyl ester hydrochloride5680-80-8//
Boc-L-serine methyl ester2766-43-0//
BOC-SER(TOS)-OCH356926-94-4//
Boc-Beta-iodo-Ala-Ome93267-04-0//
4-(Aminocarbonyl)-N-[(1,1-dimethylethoxy)carbonyl]-2,6-dimethyl-L-phenylalanine623950-02-7//
L-Alanine, N-[(phenylmethoxy)carbonyl]-, 2-oxo-2-phenylethyl ester6530-41-2//
Carbamic acid, [(1S)-1-(4-phenyl-1H-imidazol-2-yl)ethyl]-, phenylmethyl ester oxalate1993394-57-2//
(S)-1-(4-Phenyl-1H-imidazol-2-yl)ethanamine864825-23-0//
Methyl 5-formyl-2-methoxybenzoate78515-16-9//

Other programs under E

Edoxaban tosylate monohydrateElacestrantElagolix SodiumEldecalcitolElinzanetantElobixibatEltrombopagEltrombopag Olamine

Building toward Eluxadoline?

Tell us the step you need covered and the specification you are filing against. We will confirm supply, documentation and lead time.

提交项目 联系团队

我们能如何帮助您？

获取最新活动与法规动态洞察

直接发送到您的邮箱

在此获取行业洞察与 Unibest 动态

联系我们 →